Economic evaluation of the use of octreotide for prevention of complications following pancreatic resection
- 1 May 1999
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 3 (3) , 225-232
- https://doi.org/10.1016/s1091-255x(99)80064-x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitisBritish Journal of Surgery, 1995
- The relative effectiveness of somatostatin and octreotide therapy in pancreatic diseaseAlimentary Pharmacology & Therapeutics, 1995
- The Effects of Regionalization on Cost and Outcome for One General High-Risk Surgical ProcedureAnnals of Surgery, 1995
- Effect of Octreotide Acetate on Pancreatic Exocrine and Endocrine Functions after Pancreatoduodenal ResectionEuropean Surgical Research, 1995
- Efficacy of octreotide in the prevention of complications of elective pancreatic surgeryBritish Journal of Surgery, 1994
- The Role of Somatostatin and Octreotide in Pancreatic Surgery and in Acute and Chronic PancreatitisDigestive Surgery, 1994
- Prophylaxis of Complications after Pancreatic Surgery: Results of a Multicenter Trial in ItalyDigestion, 1994
- Role of somatostatin and somatostatin analogues in the treatment of gastrointestinal diseases: prevention of complications after pancreatic surgery.Gut, 1994
- Meta-Analyses of Randomized Controlled TrialsNew England Journal of Medicine, 1987
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986